Cargando…
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials
BACKGROUND: Hospital-acquired and ventilator-associated pneumonia (HAP/VAP) are often selected for randomized clinical trials (RCTs) aiming at new drug approval. Guidelines for the design of such RCTs have been repeatedly updated by regulatory agencies. We hypothesized that large variability in the...
Autores principales: | Weiss, Emmanuel, Essaied, Wafa, Adrie, Christophe, Zahar, Jean-Ralph, Timsit, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488424/ https://www.ncbi.nlm.nih.gov/pubmed/28655326 http://dx.doi.org/10.1186/s13054-017-1755-5 |
Ejemplares similares
-
What is new in non-ventilated ICU-acquired pneumonia?
por: Saied, Wafa Ibn, et al.
Publicado: (2020) -
Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa
por: Kaminski, Catherine, et al.
Publicado: (2011) -
Update on ventilator-associated pneumonia
por: Timsit, Jean-Francois, et al.
Publicado: (2017) -
Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial
por: Foucrier, Arnaud, et al.
Publicado: (2023) -
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance
por: Adrie, Christophe, et al.
Publicado: (2013)